A
Acurex Biosciences develops novel therapeutics for age-related neurodegeneration and movement disorders by targeting upstream drivers of disease progression. The company utilizes evidence from human research, in vivo models, and proprietary cellular systems to create druggable and clinically translatable programs. Their late-preclinical assets are validated through external collaborations and aim to deliver best-in-class therapies to patients via a partner-first development strategy.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Acurex Biosciences develops novel therapeutics for age-related neurodegeneration and movement disorders by targeting upstream drivers of disease progression. The company utilizes evidence from human research, in vivo models, and proprietary cellular systems to create druggable and clinically translatable programs. Their late-preclinical assets are validated through external collaborations and aim to deliver best-in-class therapies to patients via a partner-first development strategy.